PentaBase ApS of Odense C at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

PentaBase ApS

Lumbyvej 19G, 5000 Odense C
Denmark

Hall map

MEDICA 2018 hall map (Hall 3): stand F53

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.01  DNA testing

DNA testing

Our products

Product category: DNA testing

cDNA Supreme

Random Hexamer Primers are a mixture of oligonucleotides representing all possible sequence for that size. Random Primers can be used to prime synthesis in oligo-labeling similar to using hexamers and cDNA synthesis.

Random Hexamer Primers consist of a mixture of oligonucleotides representing all possible hexamer sequences. Random Hexamer Primers are commonly used for priming single-stranded DNA or RNA for extension by DNA polymerases or reverse transcriptases.

During cDNA generation, random priming gives random coverage to all regions of the RNA to generate a cDNA pool containing various lengths of cDNA. Random priming is incapable of distinguishing between mRNA and other RNA species present in the reaction

Applications
  • DNA synthesis using Klenow fragment with DNA templates
  • DNA probe synthesis for use in Northern and Southern blots, and in situ hybridization applications
  • Partially degraded RNA samples
  • RNA without poly(A) tail such as ribosomal RNAs
  • RNA with strong secondary structure
  • Target regions at 5´ end of a long messenger RNA transcript

More Less

About us

Company details

Real-Time PCR Innovators
PentaBase is a knowledge-based Danish biotech company founded and managed by researchers and located in the heart of Denmark. We specialize in custom oligonucleotide production and development of in vitro diagnostic assays for real-time PCR with special focus on detection of somatic mutations in cancer. For more than 10 years, PentaBase has created products for researchers and medical professionals exploring new treatments and helping patients worldwide.

Our products are based on our proprietary technology, Intercalating Nucleic Acids (INAs®), giving our products unique abilities in analysis and manipulation of genetic material. These features are used by medical professionals and researchers to help treat diseases and acquire new knowledge. We believe in open-platform designs and strive to make our products compatible with basic instruments used in molecular biology facilities around the world.

Our visions are:
  • To enable detection of treatable diseases as early as possible
  • To broaden and improve the use of personalized treatment of genetic diseases and cancer
  • To reduce the number of false negative samples by improving sensitivity and reducing complexity of genetic analyses
We are continuously working with researchers and the research community to develop new products, and are always open for new collaborations. If you have a challenge in genetic analysis, then talk to us.

More Less